The meningococcal B vaccine MenB protects against a fifth type of meningococcal bacterium called type B. It is fairly new and not yet recommended as a routine vaccination for healthy people.
But some kids and teens who are at increased risk for meningococcal disease should get it starting from age Others who are not at increased risk may also get it between the ages of 16 and 23 preferably between 16 through 18 as that is when the risk of getting infected is highest. The decision to get the MenB vaccine is made by the teen, their parents, and their doctor.
When Are Meningococcal Vaccines Given? Vaccination with MenACWY is recommended: when kids are 11 or 12 years old, with a booster given at age 16 for teens 13—18 years old who haven't been vaccinated yet Those who have their first dose between the ages of 13—15 should get a booster dose between the ages of 16— This includes kids who: live in or travel to countries where the disease is common are present during an outbreak of the disease have some kinds of immune disorders.
If the immune disorders are chronic, these kids also need a booster dose a few years later, depending on their age at the first dose. Why Are Meningococcal Vaccines Recommended?
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website. You will be subject to the destination website's privacy policy when you follow the link. CDC is not responsible for Section compliance accessibility on other federal or private website.
Cancel Continue. Adult Vaccination. Screening Checklists. Ask the Experts. Shop IAC. CDC Schedules. Standing Orders for Vaccination. Clinic Tools. State Laws and Mandates. Handouts for Patients and Staff. Technically Speaking.
Honor Rolls for Patient Safety. Unprotected People Stories. IAC Express. Vaccine Information Statements. View All Materials. Pregnancy and Vaccines. Top Handouts. Topic Index. Vaccine Index. Schedules for Patients.
Language Index. Administering Vaccines. Standing Orders Templates. Adolescent Vaccination. Storage and Handling. Strategies and Policies. Temperature Logs. Documenting Vaccination. Vaccine Confidence.
Healthcare Personnel. Vaccine Recommendations. Managing Vaccine Reactions. Promotional Materials. Parent Handouts. What's New: Handouts. Related Tools:. Documenting Vaccinations. IAC Express - Subscribe. Scheduling Vaccines. Image Library.
Screening for Contraindications. Vaccinating Adults Guide. Translations Index. English-language VISs. Spanish-language VISs. What's New: VISs. Hepatitis A. Hepatitis B. Varicella chickenpox. Zoster shingles. View All. Religious Concerns. Alternative Medicine. Responding to Parents. Alternative Schedules. Too Many Vaccines? Importance of Vaccines. Vaccine Safety. MMR Vaccine. IAC Home. Meningococcal ACWY. Ask the Experts Home.
Billing and Reimbursement. Combination Vaccines. Contraindications and Precautions. Meningococcal B. Travel Vaccines. Disease Issues. For People with Risk Factors. Booster Doses. Vaccine Storage and Handling. Please tell us about meningococcal disease. The following groups are at increased risk for all meningococcal serogroups:. People with persistent genetic complement component deficiencies a type of immune system disorder.
People who use complement inhibitors such as eculizumab Soliris, Alexion Pharmaceuticals and ravulizumab Ultomiris, Alexion Pharmaceuticals for treatment of atypical hemolytic uremic syndrome or paroxysmal nocturnal hemoglobinuria.
People with anatomic or functional asplenia. Microbiologists routinely exposed to meningococcal isolates in a laboratory. People at increased risk during an outbreak of meningococcal disease. Get more information about meningococcal vaccine recommendations for teenagers: Meningococcal Vaccination for Preteens and Teens: Information for Parents. Because of age or health conditions, some people should not get certain vaccines or should wait before getting them.
Tell the person who is giving you or your child a meningococcal vaccine if:. This immune response suggests the vaccines provide protection, but data are limited on how well they work. Since meningococcal disease is uncommon, many people need to get these vaccines in order to measure their effectiveness. Getting the year-old MenACWY booster dose is critical so teens have protection when they are most at risk for meningococcal disease. Available data on MenB vaccines suggest that protective antibodies also decrease quickly within 1 to 2 years after vaccination.
Rates of meningococcal disease have declined in the United States since the s and remain low today. In addition, serogroup B meningococcal disease declined even though MenB vaccines were not available until the end of These data suggest MenACWY vaccines have provided protection to those vaccinated, but probably not to the larger, unvaccinated community population or herd immunity.
Experts also believe MenB vaccines do not provide protection to unvaccinated people through population immunity. Most people who get a meningococcal vaccine do not have any serious problems with it.
0コメント